The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Open accessAbstract
Studies of the involvement of ECM molecules in cell attachment, growth, and differentiation have revealed a central role of heparan sulfate (HS) proteoglycans (HSPGs) in early embryogenesis, morphogenesis, angiogenesis, and epithelial-mesenchymal interactions (1–3). HS chains bind a multitude of proteins and ensure that a wide variety of bioactive molecules (e.g., heparin-binding growth factors, chemokines, lipoproteins, and enzymes) cling to the cell surface and ECM. HSPGs can thus influence a variety of normal and pathologic processes, among which are tissue repair, neurite outgrowth, inflammation and autoimmunity, tumor growth and metastasis, vasculogenesis and angiogenesis (1–4). Binding to HS can modulate a tethered molecule’s biological activity or protect it from proteolytic cleavage and inactivation. Transmembrane and phospholipid-anchored HSPGs (syndecans and glypicans, respectively) mediate cell interactions with components of the microenvironment that control cell shape, adhesion, proliferation, survival, and differentiation (2, 3). These species of HSPGs can also serve as coreceptors along with the other cell surface molecules to form functional receptor complexes that transduce signals from various ligands (2, 3). Because of the important and multifaceted roles of HSPGs in cell physiology, their cleavage is likely to alter the integrity and functional state of tissues and to provide a mechanism by which cells can respond rapidly to changes in the extracellular environment. Enzymatic degradation of HS is, therefore, likely to be involved in fundamental biological phenomena, ranging from pregnancy, morphogenesis, and development to inflammation, angiogenesis, and cancer metastasis. Contrary to some early claims, there is no good evidence for more than one endogenous mammalian HS-degrading endoglycosidases. The recent cloning of a single gene by several groups (5–10), together with biochemical studies (11), suggests that mammalian cells express primarily a single dominant heparanase enzyme (12). This Perspective focuses on the molecular properties, expression pattern, biological functions, and clinical significance of this heparanase in normal and pathological processes, with emphasis on tumor metastasis and angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
PROTEOGLYCANS: STRUCTURES AND INTERACTIONS
Kjellén, L., & Lindahl, U. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.002303 · Cited by 1,719
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
Iozzo, R. V. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.609 · Cited by 1,637
Proteoglycans: Structures And Interactions
Kjellen, L. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.60.1.443 · Cited by 1,594
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., & Werb, Z. (1999) · Cell · doi:10.1016/s0092-8674(00)81009-0 · Cited by 924
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Self-citationBorsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714 · cited 2×
“While the mechanism underlying this correlation is in need of study, treatment with low molecular weight heparin has been observed to confer a lower mortality rate on cancer patients (35).”
BackgroundCloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
Hulett, M. D., Freeman, C., Hamdorf, B. J., Baker, R. T., Harris, M. J., & Parish, C. R. (1999) · Nature Medicine · doi:10.1038/10525 · Cited by 518
Heparanase: a key enzyme involved in cell invasion
Parish, C. R., Freeman, C., & Hulett, M. D. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00017-8 · Cited by 466
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
Iozzo, R. V., & San Antonio, J. D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13738 · Cited by 455
Parish, C. R., Freeman, C. G., Brown, K. J., Francis, D. J., & Cowden, W. B. (1999) · PubMed · Cited by 445
Heparanase as mediator of angiogenesis: mode of action
Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo, O., Pecker, I., & Vlodavsky, I. (2001) · The FASEB Journal · doi:10.1096/fj.00-0895fje · Cited by 310
Self-citationHeparanases and tumor metastasis
Nakajima, M., Irimura, T., & Nicolson, G. L. (1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240360207 · Cited by 305
Vlodavsky, I., Eldor, A., Haimovitz‐Friedman, A., Matzner, Y., Ishai-Michaeli, R., Lider, O., Naparstek, Y., Cohen, I. R., & FUKS, Z. Y. (1992) · PubMed · Cited by 302
Self-citationToyoshima, M., & Nakajima, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24153 · Cited by 297
Vlodavsky, I., Miao, H.-Q., Medalion, B., Danagher, P., & Ron, D. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437470 · Cited by 286
Self-citationSubstrate Specificity of Heparanases from Human Hepatoma and Platelets
Pikas, D. S., Li, J.-P., Vlodavsky, I., & Lindahl, U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18770 · Cited by 261
Self-citationHeparanase expression in primary and metastatic pancreatic cancer.
Koliopanos, A., Friess, H., Kleeff, J. H., et al. (2001) · PubMed · Cited by 237
Control of Angiogenesis by Heparin and Other Sulfated Polysaccharides
Folkman, J., & Shing, Y. (1992) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4899-2444-5_34 · Cited by 224
Expression of Heparanase in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa and Stroma
Friedmann, Y., Vlodavsky, I., Aingorn, H., Aviv, A., Peretz, T., Pecker, I., & Pappo, O. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64632-9 · Cited by 202
Self-citationProcessing of the Human Heparanase Precursor and Evidence That the Active Enzyme Is a Heterodimer
Fairbanks, M. B., Mildner, A. M., Leone, J. W., Cavey, G. S., Mathews, W. R., Drong, R. F., Slightom, J. L., Bienkowski, M. J., Smith, C. W., Bannow, C. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29587 · Cited by 198
Cloning and Expression Profiling of Hpa2, a Novel Mammalian Heparanase Family Member
McKenzie, E., Tyson, K., Stamps, A., Smith, P., Turner, P., Barry, R., Hircock, M., Patel, S., Barry, E., Stubberfield, C., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3586 · Cited by 193
Heparanase, a potential regulator of cell–matrix interactions
Dempsey, L. A., Brunn, G. J., & Platt, J. L. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01619-4 · Cited by 173
Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky, I., Mohsen, M., Lider, O., Cm, S., Hp, E., Vigoda, M., Ishai-Michaeli, R., & Peretz, T. (1994) · PubMed · Cited by 170
Self-citationParish, C. R., Coombe, D. R., Jakobsen, K. B., Bennett, F. A., & Underwood, P. A. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400414 · Cited by 158
Identification of Active-Site Residues of the Pro-Metastatic Endoglycosidase Heparanase
Hulett, M. D., Hornby, J. R., Ohms, S., Zuegg, J., Freeman, C. G., Gready, J. E., & Parish, C. R. (2000) · Biochemistry · doi:10.1021/bi002080p · Cited by 152
Andela, V. B., Schwarz, E. M., Puzas, J. E., O’Keefe, R. J., & Rosier, R. N. (2000) · PubMed · Cited by 149
Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.
Marchetti, D., Li, J., & Shen, R. (2000) · PubMed · Cited by 140
Gilat, D., Hershkoviz, R., Goldkorn, I., Cahalon, L., Korner, G., Vlodavsky, I., & Lider, O. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1929 · Cited by 118
Self-citationMollinedo, F., Nakajima, M., LLORENS, A., Barbosa, E., Callejo, S., Gajate, C., & Fabra, À. (1997) · Biochemical Journal · doi:10.1042/bj3270917 · Cited by 111
Goldshmidt, O., Zcharia, E., Aingorn, H., Guatta-Rangini, Z., Atzmon, R., Michal, I., Pecker, I., Mitrani, E., & Vlodavsky, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102462200 · Cited by 86
Self-citationGenomic organization and chromosome localization of the newly identified human heparanase gene
Dong, J., Kukula, A. K., Toyoshima, M., & Nakajima, M. (2000) · Gene · doi:10.1016/s0378-1119(00)00251-1 · Cited by 79
Zcharia, E., Metzger, S., Chajek-Shaul, T., Friedmann, Y., Pappo, O., Aviv, A., Elkin, M., Pecker, I., Peretz, T., & Vlodavsky, I. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011375624902 · Cited by 74
Self-citationExtracellular Matrix-Bound Growth Factors, Enzymes, and Plasma Proteins
Vlodavsky, I., Bar‐Shavit, R., Korner, G., & FUKS, Z. Y. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-593165-6.50022-x · Cited by 64
Self-citation
Cited by
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383
IL-1 is required for tumor invasiveness and angiogenesis
Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., & Apte, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437939100 · Cited by 1,023
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis
Chang, C., & Werb, Z. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02122-5 · Cited by 683
Metadata
- Authors
- Vlodavsky, I., & Friedmann, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-08-01
- Volume
- 108
- Issue
- 3
- Pages
- 341-347
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2100959766
- Cited by
- 618
- References
- 35
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.